A detailed history of Flagship Harbor Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 1,522 shares of VRTX stock, worth $764,728. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,522
Previous 1,908 20.23%
Holding current value
$764,728
Previous $797,000 11.29%
% of portfolio
0.04%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$460.0 - $505.78 $177,560 - $195,231
-386 Reduced 20.23%
1,522 $707,000
Q1 2024

Apr 16, 2024

SELL
$407.69 - $446.08 $1,630 - $1,784
-4 Reduced 0.21%
1,908 $797,000
Q4 2023

Jan 10, 2024

BUY
$343.0 - $410.68 $116,963 - $140,041
341 Added 21.71%
1,912 $777,000
Q3 2023

Oct 17, 2023

BUY
$338.18 - $362.46 $23,672 - $25,372
70 Added 4.66%
1,571 $546,000
Q2 2023

Jul 11, 2023

BUY
$314.42 - $351.91 $31,442 - $35,191
100 Added 7.14%
1,501 $528,000
Q1 2023

Apr 12, 2023

SELL
$283.23 - $323.1 $73,923 - $84,329
-261 Reduced 15.7%
1,401 $441,000
Q4 2022

Jan 13, 2023

SELL
$285.76 - $321.48 $17,717 - $19,931
-62 Reduced 3.6%
1,662 $0
Q3 2022

Oct 13, 2022

BUY
$273.83 - $305.53 $111,174 - $124,045
406 Added 30.8%
1,724 $499,000
Q2 2022

Jul 13, 2022

BUY
$234.96 - $292.55 $3,289 - $4,095
14 Added 1.07%
1,318 $371,000
Q1 2022

Apr 13, 2022

SELL
$221.42 - $260.97 $2,657 - $3,131
-12 Reduced 0.91%
1,304 $340,000
Q4 2021

Feb 10, 2022

BUY
$177.01 - $223.45 $37,880 - $47,818
214 Added 19.42%
1,316 $289,000
Q2 2021

Jul 26, 2021

BUY
$187.49 - $221.1 $206,613 - $243,652
1,102 New
1,102 $222,000
Q4 2020

Feb 08, 2021

SELL
$207.01 - $276.09 $164,365 - $219,215
-794 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$255.65 - $303.1 $18,918 - $22,429
74 Added 10.28%
794 $216,000
Q2 2020

Jul 31, 2020

BUY
$225.48 - $295.8 $33,371 - $43,778
148 Added 25.87%
720 $209,000
Q1 2020

May 12, 2020

BUY
$199.77 - $247.81 $11,586 - $14,372
58 Added 11.28%
572 $136,000
Q2 2019

Jul 22, 2019

BUY
$164.61 - $190.37 $2,633 - $3,045
16 Added 3.21%
514 $94,000
Q4 2018

Jan 28, 2019

SELL
$151.91 - $192.21 $34,635 - $43,823
-228 Reduced 31.4%
498 $82,000
Q3 2018

Nov 05, 2018

SELL
$167.73 - $192.74 $1,845 - $2,120
-11 Reduced 1.49%
726 $139,000
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $107,395 - $125,260
737 New
737 $125,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.